Biotricity
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Biotricity generated cash of -$6,693,912, which is more than the previous year. Cash used in financing activities reached the amount of $6,741,685 last year. Net change in cash is therefore $215,600.
Cash Flow
| 2014 | -8.22K | 0 | 8.22K |
|---|---|---|---|
| 2014 | -26.95K | 0 | 31.36K |
| 2017 | -3.74M | 0 | 3.96M |
| 2018 | -4.87M | 0 | 5.28M |
| 2019 | -5.22M | 0 | 4.55M |
| 2020 | -7.86M | 0 | 8.87M |
| 2021 | -11.08M | 0 | 12.20M |
| 2022 | -15.16M | -29.76K | 25.16M |
| 2023 | -13.54M | 0 | 2.00M |
| 2024 | -6.69M | 0 | 6.74M |
BTCY Cash Flow Statement (2014 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 570.46K | 12.06M | 2.20M | 949.84K | 63.64K | 843.64K | 424.86K | 53.64K | 1.06K | 0 |
Operating activities | ||||||||||
Net income | -14.09M | -18.65M | -29.13M | -15.49M | -11.06M | -8.59M | -8.62M | -7.80M | -90.81K | -91.07K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.17M | 5.95K | 2.30K | 347.11K | 148.76K | 0 | 0 | 0 | 9.05K | 0 |
Stock-based compensation expense | 1.02M | 647.63K | 913.61K | 790.53K | 2.40M | 1.45M | 1.00M | 626.13K | 466.51K | 0 |
| Deferred income tax benefit | 1.02M | 647.63K | 913.61K | 790.53K | 2.40M | 1.45M | 1.00M | 626.13K | 466.51K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -298.24K | 686.19K | -435.48K | -1.03M | -326.20K | -208.09K | -34.79K | 28.61K | 0 | 0 |
Inventories | 457.60K | -1.49M | -570.43K | -186.77K | -61.11K | -24.60K | 0 | 0 | 0 | 0 |
Accounts payable | 3.27M | 3.34M | 948.99K | 752.35K | 75.73K | 652.69K | 0 | 0 | 60.2K | 64.85K |
Cash generated by operating activities | -6.69M | -13.54M | -15.16M | -11.08M | -7.86M | -5.22M | -4.87M | -3.74M | -26.95K | -8.22K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -29.76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -29.76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 119.28K | 12.5K | 14.79M | 267.94K | 28.56K | 3.63M | 4.86M | 1.23M | 45K | 0 |
Payments for dividends | -18.01K | -946.78K | -966.11K | -602.96K | -180K | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -895.55K | -230K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 3.81M | 3.83M | 10.59M | -408.08K | -1.20M | 867.69K | 0 | 2.45M | 13.56K | 0 |
Cash used in financing activities | 6.74M | 2.00M | 25.16M | 12.20M | 8.87M | 4.55M | 5.28M | 3.96M | 31.36K | 8.22K |
Net Change In Cash | 215.6K | -11.49M | 9.86M | 1.25M | 886.20K | -779.99K | 418.77K | 371.22K | 3.34K | 0 |
Cash at end of period | 786.06K | 570.46K | 12.06M | 2.20M | 949.84K | 63.64K | 843.64K | 424.86K | 4.41K | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |